Ionis Pharmaceuticals (IONS) Other Non Operating Income (2012 - 2026)

Ionis Pharmaceuticals' Other Non Operating Income history runs 12 years deep, the most recent figure standing at -$456000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 198.06% year-over-year to -$456000.0 in Q1 2026; TTM through Mar 2026 was -$1.0 million, a 376.06% decrease from a year earlier, with the FY2025 full-year figure at -$118000.0, down 162.77% from the prior year.
• Other Non Operating Income climbed to -$456000.0 in Q1 2026 per IONS's latest filing, from -$1.0 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $11.2 million in Q2 2023 and bottomed at -$13.5 million in Q4 2023.
• The 5-year median for Other Non Operating Income is $230000.0 (2023), against an average of $31058.8.
• Across the five-year window, Other Non Operating Income surged 6133.33% in 2022 and plunged 269.55% in 2023, its largest moves.
• Year by year, Other Non Operating Income stood at $8.0 million in 2022, then plunged by 269.55% to -$13.5 million in 2023, then surged by 93.78% to -$841000.0 in 2024, then dropped by 24.49% to -$1.0 million in 2025, then surged by 56.45% to -$456000.0 in 2026.
• Per Business Quant, the three latest IONS Other Non Operating Income figures stand at -$456000.0 (Q1 2026), -$1.0 million (Q4 2025), and $363000.0 (Q3 2025).